Long-term outcomes with first-line nivolumab plus ipilimumab in advanced NSCLC: 3-year follow-up from CheckMate 012 Meeting Abstract
| Authors: | Antonia, S.; Gettinger, S.; Borghaei, H.; Goldman, J. W.; Brahmer, J.; Ready, N.; Gerber, D.; Chow, L.; Juergens, R.; Laurie, S.; Shepherd, F.; Li, X.; Li, A.; Geese, W.; Hellmann, M. |
| Abstract Title: | Long-term outcomes with first-line nivolumab plus ipilimumab in advanced NSCLC: 3-year follow-up from CheckMate 012 |
| Meeting Title: | IASLC 19th World Conference on Lung Cancer |
| Keywords: | nsclc; first-line; nivolumab |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 13 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2018 Sep 23-26 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2018-10-01 |
| Start Page: | S458 |
| Language: | English |
| ACCESSION: | WOS:000454014501192 |
| DOI: | 10.1016/j.jtho.2018.08.558 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P1.01-02 -- Source: Wos |
